Macfarlane K. Angela 4
4 · RenovoRx, Inc. · Filed Mar 14, 2022
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Macfarlane K. Angela
Director
Transactions
- Award
Stock option (right to buy)
2022-03-10−4,582→ 4,582 totalExercise: $3.17Exp: 2032-03-10→ Common Stock (4,582 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in twelve equal monthly installments beginning on November 1, 2021.